Skip to main content
Erschienen in: Virology Journal 1/2019

Open Access 01.12.2019 | Research

Characteristics of human papillomaviruses distribution in Guizhou Province, China

verfasst von: Zuyi Chen, Qiongyao Li, Qiong Huang, Huaqing Liu, Hongwu Jiang, Zehui Chen, Zhengyuan An, Qingfang Luo

Erschienen in: Virology Journal | Ausgabe 1/2019

Abstract

Background

Human papillomavirus (HPV) is one of the most common sexually transmitted viruses. Data about HPV infection in Guizhou is limited.

Methods

56,768 cervical samples were collected and genotyped for 15 main high risk and 6 main low risk HPV types.

Results

16.95% (9623/56768) of samples were HPV positive; 90.70% (8728/9623) of HPV positive women were infected by high risk HPV. High risk and high risk mix infection (1458; 70.85%) was the most common mix HPV infection type. The highest HPV detection rate was found in age group 41–45 years old (detection rate = 17.89%) (χ2 = 204.77; P < 0.001); the highest within-group HPV infection rates were found in the ≤20 (25.62%) and ≥ 61 (24.67%) years old age groups, the lowest within-group HPV infection rate was found in the 31–35 years old age group (15.02%). The highest mix infection proportions were found in the ≥61 (36.06%) and ≤ 20 (33.63%) years old age groups (χ2 = 111.21; P < 0.001), the lowest mix infection proportion was found in the 41–45 (17.42%) years old age group. The highest high risk infection proportions were found in the 26–30 (92.98%), ≥61 (92.68%), and 36–40 (92.16%) years old age groups (χ2 = 31.72; P < 0.001), the lowest high risk infection proportion was found in the ≤20 (84.96%) years old age group. HPV infection rates varied with seasons in Guizhou.

Conclusions

Characteristics of HPV distribution in Guizhou were identified. There were significant differences in HPV distribution among age groups, prevention strategies should be adjusted according to the characteristics.
Hinweise
Zuyi Chen and Qiongyao Li contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
HPV
Human papillomavirus

Introduction

Human papillomavirus (HPV) is associated with varied epithelial lesions, including cervical intraepithelial neoplasia and genital warts [1]. Cervical cancer is one of the most common malignant tumors among women worldwide, genital warts is also very prevalent among women; each year about 500,000 new cases of cervical cancer and 1 million new cases of genital warts were diagnosed worldwide [2, 3].
More than 200 HPV types have been identified until now (pave.​niaid.​nih.​gov). “High-risk” and “low-risk” were used to distinguish different HPV types according to their risks in causing malignant tumors. HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 83 are common high risk types; HPV 6, 11, 40, 42, 43, 44, 54, 61, 70, 72, and 81 are common low risk types [4].
HPV distribution varies geographically considerably. Effective HPV prevention and treatment strategies should be specialized based on local HPV distribution characteristics [5]. There is little data about HPV distribution characteristics in Guizhou, China. Guizhou is a province with 36 million people (data from National Bureau of Statistics of China, http://​www.​stats.​gov.​cn/​). This study aimed to investigate HPV distribution characteristics in Guizhou, China, to afford data for HPV prevention and treatment locally.

Methods and materials

From January 1, 2016 to December 31, 2017, cervical swabs were obtained from patients at the Affiliated Hospital of Zunyi Medical University. Women over 18 years old with visible cervical lesions and/or HPV-related diseases (e.g. cervical intraepithelial neoplasia) were eligible for inclusion. The present study was approved by the Affiliated Hospital of Zunyi Medical University Ethics Committee, the approval number was ZYFYLS2018(81). Before sample collection, informed consent was obtained.
Cervical specimens were collected by cervical brush and stored in preservative buffer solution (NaCl 9 g, sodium benzoate 10 g, H2O 1 L) at − 20 °C. Cervical specimens were detected for HPV Genotyping by a Kit (Human Papillomavirus Genotyping Kit; Yaneng Bioscience, Shenzhen, China) according to the instruction. Positive and negative controls were included in all experiments.
SPSS version 19 (IBM, Armonk, NY, USA) was used for data analysis. The Pearson χ2 test was used to confirm the results. P < 0.05 was considered statistically significant.

Results

In total, 56,768 samples (mean age 39.45 ± 9.88 years old) were collected and detected for HPV genotyping, 16.95% (9623/56768) of samples were HPV positive; 90.70% (8728/9623) of HPV positive patients were infected by high risk HPV. HPV detection number was 12,378, 87.66% (10,850/12378) were high-risk HPV types. Detection number and detection rate of high-risk types were HPV52 (2206; 17.82%), HPV16 (1713; 13.84%), HPV58 (1435; 11.59%), HPV53 (986; 7.97%), HPV39 (923; 7.46%), HPV51 (723; 5.84%), HPV18 (534; 4.31%), HPV33 (523; 4.23%), HPV68 (456; 3.68%), HPV31 (380; 3.07%), HPV66 (309; 2.50%), HPV56 (238; 1.92%), HPV59 (210; 1.70%), HPV45 (110; 0.89%), and HPV35 (104; 0.84%). Detection number and detection rate of low-risk types were HPV81 (769; 6.21%), HPV6 (262; 2.12%), HPV11 (241; 1.95%), HPV44 (145; 1.17%), HPV43 (63; 0.51%), and HPV42 (48; 0.39%).
Women were divided into different age groups. The highest HPV detection rate was found in age group 41–45 years old (detection rate = 17.89%) (χ2 = 204.77; P < 0.001) (see Table 1); but the highest within-group HPV infection rates were found in the ≤20 (25.62%) and ≥ 61 (24.67%) years old age groups, the lowest within-group HPV infection rate was found in the 31–35 years old age group (15.02%) (see Table 1). The highest mix infection proportions were found in the ≥61 (36.06%) and ≤ 20 (33.63%) years old groups (χ2 = 111.21; P < 0.001), the lowest mix infection proportion was found in the 41–45 (17.42%) years old age group (see Table 2). The highest high risk infection proportions were found in the 26–30 (92.98%), ≥61 (92.68%), and 36–40 (92.16%) years old groups (χ2 = 31.72; P < 0.001), the lowest high risk infection proportion was found in the ≤20 (84.96%) years old age group (see Table 2).
Table 1
Detection rate and positive rate of patients in each age group
age
Positive number
Negative number
Total
Detection rate
Positive rate
≤20
113
328
441
1.17%
25.62%
21–25
739
2807
3546
7.68%
20.84%
26–30
1410
6765
8175
14.65%
17.25%
31–35
1285
7273
8558
13.35%
15.02%
36–40
1530
8280
9810
15.90%
15.60%
41–45
1722
9331
11,053
17.89%
15.58%
46–50
1320
6469
7789
13.72%
16.95%
51–55
871
3821
4692
9.05%
18.56%
56–60
278
987
1265
2.89%
21.98%
≥61
355
1084
1439
3.69%
24.67%
Total
9623
47,145
56,768
100.00%
16.95%
Note: Detection rate means positive number percentage of each age group in total positive number. After rounding of “Detection rate” in each age group, the “Detection rate” arithmetic sum of all age group was not 100.00%
Table 2
High risk proportion and mix infection proportion of each age group
age
High risk infection
Only low risk infection
High risk proportion
Mix infection
Single infection
Mix infection proportion
≤20
96
17
84.96%
38
75
33.63%
21–25
676
63
91.47%
193
546
26.12%
26–30
1311
99
92.98%
313
1097
22.20%
31–35
1168
117
90.89%
249
1036
19.38%
36–40
1410
120
92.16%
272
1258
17.78%
41–45
1527
195
88.68%
300
1422
17.42%
46–50
1183
137
89.62%
299
1021
22.65%
51–55
777
94
89.21%
182
689
20.90%
56–60
251
27
90.29%
84
194
30.22%
≥61
329
26
92.68%
128
227
36.06%
total
8728
895
90.70%
2058
7565
21.39%
Note: High risk infection, Only low risk infection, Mix infection, Single infection mean positive patients number of high risk infection, only low risk infection, mix infection, and single infection, respectively. High risk proportion means high risk infection number percentage of each age group in total number of both high risk infection and only low risk infection. Mix infection proportion means mix infection number percentage of each age group in total number of both mix infection and single infection
The number and detection rate of different HPV types detected per patient were listed in Table 3. At most eight infection was found. High risk and high risk mix infection (1458; 70.85%) was the most common mix HPV infection type with overriding advantage (see Table 3).
Table 3
Percentage of single infection and mixed infections
Type
Number
Positive rate
Detection rate
single
7565
13.326%
78.61%
double
1561
2.750%
16.22%
three
360
0.634%
3.74%
four
97
0.171%
1.01%
five
25
0.044%
0.26%
six
8
0.014%
0.08%
seven
6
0.011%
0.06%
eight
1
0.002%
0.01%
Total
9623
16.95%
100.00%
HR-HR
1458
2.57%
70.85%
HR-LR
580
1.02%
28.18%
LR-LR
20
0.04%
0.97%
Total
2058
3.63%
100.00%
Note: Single, double, three, four, five, six, seven, eight means single, double, three, four, five, six, seven, eight infection, respectively. HR-HR means high-risk and high-risk mixed infection; HR-LR means high-risk and low-risk mixed infection; LR-LR means low-risk and low-risk mixed infection. Positive rate means positive number percentage of each infection type in total patients. Detection rate means positive number percentage of each infection type in total positive number. After rounding, the “Detection rate” arithmetic sum of single, double, three, four, five, six, seven and eight infection was not 100.00%
HPV positive rates of different seasons were analyzed. Months were divided into Spring (March, April and May), Summer (June, July and August), Autumn (September, October and November) and Winter (January, February and December) according to the standard QX/T152–2012 of China Meteorological Information Center (data.​cma.​cn). We found that positive rate of HPV varied with seasons. The highest and lowest (χ2 = 39.46.; P < 0.001) HPV positive rates were found in Spring (2699/14600; 18.49%) and Autumn (2148/13601; 15.79%), respectively (see Table 4).
Table 4
Positive rates of four seasons
Season
Positive number
Negative number
Positive rate
Spring
2699
11,901
18.49%
Summer
2848
14,369
16.54%
Autumn
2148
11,453
15.79%
Winter
1928
9422
16.99%
Total
9623
47,145
16.95%
Note: Positive number and Negative number mean HPV positive and HPV negative number patients in each season. Positive rate means positive number percentage in total patients of each season

Discussion

This study investigated the HPV distribution characteristics in Guizhou. This is the first HPV distribution study with large sample size in Guizhou. Data presented in this study was useful for HPV detection, prevention and treatment in Guizhou.
HPV16, HPV18, HPV31, HPV58 and HPV52 were the five most common high risk HPV types worldwide; HPV16 and HPV18 account for approximately 70% of cervical cancer cases [6, 7]. While HPV16, HPV52, HPV18, HPV51 and HPV58 were the five most common high risk HPV types in China [6]. In the present study, HPV52, HPV16, HPV58, HPV53 and HPV39 were the five most common high risk HPV types in Guizhou. HPV53, HPV39 and HPV51 were more common than HPV18; HPV53 and HPV51 were rarely reported as the most common types in China recently [814]. No HPV vaccine target HPV53, HPV39 and HPV51 until now. So HPV53, HPV39 and HPV51 should be important targets of high risk HPV prevention by detection. HPV vaccine for HPV53, HPV39 and HPV51 should be developed for Guizhou.
HPV6 and HPV11 were the most common low risk HPV types worldwide and in China [9]. But in the present study, we found that HPV81 was the most common low risk type with overwhelming advantage. And what was worse, no HPV vaccine target HPV81 until now. So low risk HPV prevention key target by detection may should be adjusted from HPV6 and HPV11 to HPV81. HPV81 vaccine should be developed for Guizhou.
High-risk HPV persistent infection is the main reason of cervical cancer [15]. In the present study, we found that the high risk HPV infection proportions were up to 90.70 and 92.98% in all and in 26–30 years old age group HPV positive women, respectively. Proportion of high risk HPV infection in Guizhou was much higher than studies in other recent reports in China [814].
In the present study, we found that the most prevalent HPV infection age was between 41 and 45 years old (detection rate = 17.89%), similar to few recent studies in China [9, 10], but different from most studies in and out of China [8, 1114, 16, 17]. The HPV with-in group positive rate, mix infection proportion and high risk infection proportion were all relatively high in age group ≥61. Ideal prevention strategies for Guizhou population should be developed according to the HPV distribution characteristics of each age group in Guizhou, especially for the age groups with highest HPV with-in group positive rates, mix infection proportions and high risk infection proportions.
Whether HPV mix infections increase the risk of disease is not clear. Antigens vary among different HPV types; cross-defense is not effective enough [18]. HPV mix infection may increase the risk of HPV-related diseases. Compared to similar studies, high risk and high risk HPV mix infection in Guizhou was very high [8, 9]. Age groups with higher HPV mix infection in the present study may need more attention in HPV prevention in Guizhou.
In this study, we found that there were statistical differences in HPV positive rates among different seasons, indicating that season factor should also be taken in to consideration in HPV prevention in Guizhou.

Conclusion

HPV52, HPV16, HPV58, HPV53 and HPV39 were the five most common high risk HPV types in Guizhou. HPV81 was the most common low risk type in Guizhou. High risk HPV infection proportion was very high in Guizhou. There were significant differences in HPV distribution among age groups, prevention strategy should be adjusted according to the HPV characteristics of each group. HPV infection rates varied with seasons in Guizhou.

Acknowledgments

We thank for doctors of obstetrics and gynecology department of Affiliated Hospital of Zunyi Medical University.
The study was approved by the Ethics Committee of Affiliated Hospital of Zunyi Medical University, the approval number was ZYFYLS2018(81). Before sample collection, a written informed consent was obtained from all the patients or their guardians, and patient/study subject privacy was carefully protected.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Martins TR, de Oliveira CM, Rosa LR, et al. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data[J]. Virol J. 2016;13(1):138.CrossRef Martins TR, de Oliveira CM, Rosa LR, et al. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data[J]. Virol J. 2016;13(1):138.CrossRef
2.
Zurück zum Zitat Chen Z, Jing Y, Wen Q, et al. E6 and E7 gene polymorphisms in human papillomavirus types-58 and 33 identified in Southwest China[J]. PLoS One. 2017;12(1):e0171140.CrossRef Chen Z, Jing Y, Wen Q, et al. E6 and E7 gene polymorphisms in human papillomavirus types-58 and 33 identified in Southwest China[J]. PLoS One. 2017;12(1):e0171140.CrossRef
3.
Zurück zum Zitat Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts[J]. Dermatology online journal. 2006;12(3):5–5.PubMed Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts[J]. Dermatology online journal. 2006;12(3):5–5.PubMed
4.
Zurück zum Zitat Muñoz N, Bosch FX, De Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med. 2003;348(6):518–27.CrossRef Muñoz N, Bosch FX, De Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med. 2003;348(6):518–27.CrossRef
5.
Zurück zum Zitat Chen Z, Jing Y, Wen Q, et al. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis[J]. Virol J. 2016;13(1):167.CrossRef Chen Z, Jing Y, Wen Q, et al. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis[J]. Virol J. 2016;13(1):167.CrossRef
6.
Zurück zum Zitat Castellsague X. HPV and cervical Cancer in the world: 2007 report (section I continents and regions)[J]. Vaccine. 2007;25:C1–C26.CrossRef Castellsague X. HPV and cervical Cancer in the world: 2007 report (section I continents and regions)[J]. Vaccine. 2007;25:C1–C26.CrossRef
7.
Zurück zum Zitat Ursu RG, Onofriescu M, Nemescu D, et al. HPV prevalence and type distribution in women with or without cervical lesions in the northeast region of Romania[J]. Virol J. 2011;8(1):558.CrossRef Ursu RG, Onofriescu M, Nemescu D, et al. HPV prevalence and type distribution in women with or without cervical lesions in the northeast region of Romania[J]. Virol J. 2011;8(1):558.CrossRef
8.
Zurück zum Zitat Chen Z, Wang Q, Ding X, et al. Characteristics of HPV prevalence in Sichuan Province, China[J]. Int J Gynecol Obstet. 2015;131(3):277–80.CrossRef Chen Z, Wang Q, Ding X, et al. Characteristics of HPV prevalence in Sichuan Province, China[J]. Int J Gynecol Obstet. 2015;131(3):277–80.CrossRef
9.
Zurück zum Zitat Zeng Z, Yang H, Li Z, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China's largest CAP certified laboratory[J]. J Cancer. 2016;7(9):1037.CrossRef Zeng Z, Yang H, Li Z, et al. Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China's largest CAP certified laboratory[J]. J Cancer. 2016;7(9):1037.CrossRef
10.
Zurück zum Zitat Zhao P, Liu S, Zhong Z, et al. Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China[J]. BMC Infect Dis. 2018;18(1):204.CrossRef Zhao P, Liu S, Zhong Z, et al. Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China[J]. BMC Infect Dis. 2018;18(1):204.CrossRef
11.
Zurück zum Zitat Zhao R, Zhang WY, Wu MH, et al. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study[J]. Br J Cancer. 2009;101(9):1635.CrossRef Zhao R, Zhang WY, Wu MH, et al. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study[J]. Br J Cancer. 2009;101(9):1635.CrossRef
12.
Zurück zum Zitat Chen X, Wallin KL, Duan M, et al. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China[J]. J Med Virol. 2015;87(11):1966–72.CrossRef Chen X, Wallin KL, Duan M, et al. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China[J]. J Med Virol. 2015;87(11):1966–72.CrossRef
13.
Zurück zum Zitat Wang S, Wei H, Wang N, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China[J]. BMC Cancer. 2012;12(1):160.CrossRef Wang S, Wei H, Wang N, et al. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China[J]. BMC Cancer. 2012;12(1):160.CrossRef
14.
Zurück zum Zitat Chen Q, Luo ZY, Lin M, et al. Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province[J]. Asian Pac J Cancer Prev. 2012;13(4):1519–24.CrossRef Chen Q, Luo ZY, Lin M, et al. Prevalence and genotype distribution of human papillomavirus infections in women attending hospitals in Chaozhou of Guangdong province[J]. Asian Pac J Cancer Prev. 2012;13(4):1519–24.CrossRef
15.
Zurück zum Zitat Baboci L, Boscolo-Rizzo P, Holzinger D, et al. Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma[J]. Virol J. 2013;10(1):334.CrossRef Baboci L, Boscolo-Rizzo P, Holzinger D, et al. Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma[J]. Virol J. 2013;10(1):334.CrossRef
16.
Zurück zum Zitat Anderson LA, O'Rorke MA, Wilson R, et al. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: a population-based study from Northern Ireland[J]. J Med Virol. 2016;88(7):1262–70.CrossRef Anderson LA, O'Rorke MA, Wilson R, et al. HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: a population-based study from Northern Ireland[J]. J Med Virol. 2016;88(7):1262–70.CrossRef
17.
Zurück zum Zitat Hibbitts S, Rieck GC, Hart K, et al. Human papillomavirus infection: an anonymous prevalence study in South Wales, UK[J]. Br J Cancer. 2006;95(2):226–32.CrossRef Hibbitts S, Rieck GC, Hart K, et al. Human papillomavirus infection: an anonymous prevalence study in South Wales, UK[J]. Br J Cancer. 2006;95(2):226–32.CrossRef
18.
Zurück zum Zitat Karanam B, Jagu S, Huh WK, et al. Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection[J]. Immunol Cell Biol. 2009;87(4):287–99.CrossRef Karanam B, Jagu S, Huh WK, et al. Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection[J]. Immunol Cell Biol. 2009;87(4):287–99.CrossRef
Metadaten
Titel
Characteristics of human papillomaviruses distribution in Guizhou Province, China
verfasst von
Zuyi Chen
Qiongyao Li
Qiong Huang
Huaqing Liu
Hongwu Jiang
Zehui Chen
Zhengyuan An
Qingfang Luo
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Virology Journal / Ausgabe 1/2019
Elektronische ISSN: 1743-422X
DOI
https://doi.org/10.1186/s12985-019-1239-0

Weitere Artikel der Ausgabe 1/2019

Virology Journal 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.